GE HealthCare to establish neuroscience research network
At a glance
- $GEHC today−1.35%last $81.84
- Vs industry peers−0.52 pts3-peer median −0.83% · behind
- Since Nov 10−1.25%from the first trade after the story
- 52-week range8.8% below high$58.75 – $89.77
- Last reported profit$615.0Mquarter to Sep 30, 2026 · 10-Q
- Coverage0 this week3 in 30 days · too few stories to call a pace
- Key person: Filed with SEC
- Clear: legal, regulatory, security, operational, financial integrity
Options price an average move of ±5.7% by Dec 18 — the at-the-money straddle, the typical size of the move; the bands are one standard deviation.
Early signals (2) — filed with the SEC or first reported, not yet widely covered
- Key person · SEC 8-K, Item 5.02, Nov 5: Filed: a director or officer departed, was appointed, or had their pay changed. View filing →
- Key person · SEC 8-K, Item 5.02, Oct 28: Filed: a director or officer departed, was appointed, or had their pay changed. View filing →
Close-to-close moves; beta-adjusted against the S&P 500, σ in the stock’s own daily noise; ranges one standard deviation. Reports are outlets’ words or SEC filings. Not a forecast or advice.
What it means
- What to watch: Drugmakers thrive on pipelines — late-stage trials matter more than quarterly numbers, even if they feel like a big deal right now.
- How the stock is trading: $GEHC -1.35% in the latest session.
- Timing: It was published before the opening bell, so the next session was the first chance to trade on it.
Where the stock stands
GE HealthCare Technologies ($GEHC) fell 1.35% to $81.84 in the latest session. Over the past month it is up 17.3%. That leaves it 8.8% below its 52-week high of $89.77 and 39% above its low of $58.75. The high sits 53% above the low, a wide range for one year.
What the filings say
In its latest report (10-Q, filed Oct 28, 2026), $GEHC earned $615.0M over the quarter to Sep 30, 2026 on revenue of $5.51B (+4.1% QoQ). Operations brought in $1.36B of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was $973.0M. It carried $9.97B of debt against $2.83B of cash on Sep 30, 2026 — net debt of $7.15B. Its most recent filings before this story: 8-K on Nov 5, 2026, 10-Q on Oct 28, 2026, 8-K on Oct 28, 2026. Figures are as filed with the SEC; the $GEHC page has the full statements.
How much coverage it is getting
This is one of 3 stories on GE HealthCare Technologies in Wook's last 30 days of coverage, including 0 this week. None came this week, so coverage has gone quiet. Going by their wording, 1 read bullish, 2 neutral and 0 bearish. This one reads neutral too, in line with most of them. Seeking Alpha wrote 3 of the 3 (100%), so the count reflects one outlet's output more than broad attention.
The bigger picture
Healthcare news hinges on approvals, trial results, and pricing — one FDA call or trial update can shift a drugmaker’s fate, while pricing changes ripple across the whole sector. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $GEHC page, and they say what management has disclosed without a reporter in between. Most of the recent coverage comes from one outlet, so check whether another newsroom has confirmed the story or is only repeating it. Wook AI, at the top of the page, can work out how far $GEHC is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 10, 2026. $GEHC has moved -1.25% ($82.88 to $81.84). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
